|
NFKB1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.436700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.23869999999016E-05 |
| Normal-vs-Stage2 |
1.466600E-01 |
| Normal-vs-Stage3 |
9.204000E-01 |
| Normal-vs-Stage4 |
4.189200E-01 |
| Stage1-vs-Stage2 |
2.227400E-01 |
| Stage1-vs-Stage3 |
7.5475000000047E-05 |
| Stage1-vs-Stage4 |
1.568310E-02 |
| Stage2-vs-Stage3 |
1.207830E-01 |
| Stage2-vs-Stage4 |
4.924800E-01 |
| Stage3-vs-Stage4 |
3.848200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.357100E-03 |
| Normal-vs-AfricanAmerican |
9.601600E-02 |
| Normal-vs-Asian |
1.703190E-01 |
| Caucasian-vs-AfricanAmerican |
8.165200E-01 |
| Caucasian-vs-Asian |
2.958600E-01 |
| AfricanAmerican-vs-Asian |
3.966800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.147180E-01 |
| Normal-vs-Female |
6.0590000000027E-05 |
| Male-vs-Female |
1.482390E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.799000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.989500E-04 |
| Normal-vs-Age(61-80Yrs) |
4.850200E-02 |
| Normal-vs-Age(81-100Yrs) |
9.615800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.802400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.175200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.510400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.973900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.066360E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.482600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.198000E-03 |
| Normal-vs-Grade 2 |
8.07320000000278E-05 |
| Normal-vs-Grade 3 |
1.014780E-01 |
| Normal-vs-Grade 4 |
6.716000E-01 |
| Grade 1-vs-Grade 2 |
3.622200E-02 |
| Grade 1-vs-Grade 3 |
4.916100E-03 |
| Grade 1-vs-Grade 4 |
4.972400E-04 |
| Grade 2-vs-Grade 3 |
1.724040E-02 |
| Grade 2-vs-Grade 4 |
4.993900E-04 |
| Grade 3-vs-Grade 4 |
9.443600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.42059999985733E-07 |
| Normal-vs-ccB subtype |
9.872800E-01 |
| ccA subtype-vs-ccB subtype |
5.52529999531259E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.864700E-03 |
| Normal-vs-N1 |
6.298200E-01 |
| N0-vs-N1 |
7.287200E-01 |
|
|
